Antimicrobial Peptides: a promising class of antimicrobial compounds against BWA and multi-drug resistant bacteria: in the spotlight: the lactoferrin chimera

Authors
Publication date 2014
Book title State-of-the-Art in Research on Medical Countermeasures Against Biological Agents (État de l'art dans la recherche sur les contre-mesures médicales face aux agents biologiques): STO Meeting Proceedings: MP-HFM-239
ISBN
  • 9789283720003
Event State-of-the-Art in Research on Medical Countermeasures Against Biological Agents (HFM-239)
Publisher NATO, S&I
Organisations
  • Faculty of Dentistry (ACTA)
Abstract
Anti-Microbial Peptides (AMPs) are part of the innate immune defense system and considered as promising lead compounds for the development of novel anti-bacterial agents. In general, AMPs are simple, short peptides with broad-spectrum activity against Gram-negative and Gram-positive bacteria, fungi, viruses, and parasites. AMPs are, inherently structured, to target and interact with bio-membranes. The AMPs in this study are derived from Lactoferrin. Lactoferrin is one of the antimicrobial components of the immune system of the body. In our laboratory, the antibacterial activity, cytotoxicity, the effects on host cell attachment and cell invasion of Lactoferrin and derived AMPs: lactoferricin, lactoferrampin and LFchimera (a chimera of lactoferricin and lactoferrampin) are studied against a broad range of bacteria including Bacillus antracis, Yersinia pestis and Burkholderia pseudomallei.
Document type Conference contribution
Language English
Published at https://www.cso.nato.int/Pubs/rdp.asp?RDP=STO-MP-HFM-239
Permalink to this page
Back